SKI Market

Indian Indices

Nifty

25,877.85 -176.05
(-0.68%)

Sensex

84,404.46 -592.67
( -0.70%)

Bank Nifty

58,031.10 -354.15
( -0.61%)

Nifty IT

35,906.40 -183.70
( -0.51%)

Global Indices

Nasdaq

47,640.49 -86.88
(-0.18%)

Dow Jones

6,909.03 -2.86
(-0.04%)

Hang Seng

51,378.02 70.37
(0.14%)

Nikkei 225

9,755.02 -1.12
(-0.01%)

Forex

USD-INR

88.25 0.13
(0.15%)

EUR-INR

102.86 0.33
(0.32%)

GBP-INR

117.45 -0.02
(-0.02%)

JPY-INR

0.58 0.00
(0.68%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Cipla Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500087

INE059A01026

411.5600262

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CIPLA

23.94

124437.16

EPS(TTM)

Face Value()

Div & Yield %

64.35

1.04

Back

cipla ltd

Cipla consolidated net profit rises 3.73% in the September 2025 quarter

Oct 30,2025

Net profit of Cipla rose 3.73% to Rs 1351.17 crore in the quarter ended September 2025 as against Rs 1302.53 crore during the previous quarter ended September 2024. Sales rose 6.98% to Rs 7447.42 crore in the quarter ended September 2025 as against Rs 6961.22 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	7447.42	6961.22	7
OPM %	25.44	27.09	-
PBDT	2150.52	2060.80	4
PBT	1853.53	1789.06	4
NP	1351.17	1302.53	4

25,877.85 -176.05 (-0.68%)

84,404.46 -592.67 ( -0.70%)

58,031.10 -354.15 ( -0.61%)

35,906.40 -183.70 ( -0.51%)

47,640.49 -86.88 (-0.18%)

6,909.03 -2.86 (-0.04%)

51,378.02 70.37 (0.14%)

9,755.02 -1.12 (-0.01%)

88.25 0.13 (0.15%)

102.86 0.33 (0.32%)

117.45 -0.02 (-0.02%)

0.58 0.00 (0.68%)